On August 31, 2022 Molecular Templates, Inc., (Nasdaq: MTEM, "Molecular Templates" or "MTEM") a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), reported that it will participate in the following September 2022 conferences (Press release, Molecular Templates, AUG 31, 2022, View Source [SID1234618897]). Presentation links can be found in the "News and Media" section of the corporate website. One-on-one meetings may be scheduled via conference representatives or directly with Molecular Templates.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 17th Annual BioPharma Conference, September 7 – 8, 2022

Location: Boston, MA
H.C. Wainwright 24th Annual Global Investment Conference, September 12 – 14, 2022

Location: New York, NY

Webcast Presentation: September 12, 2022, available starting 7am ET here
Morgan Stanley 20th Annual Global Healthcare Conference, September 12 – 14, 2022

Location: New York, NY
Cantor Oncology, Hematology, and HemeOnc Conference, September 28, 2022

Location: New York, NY

Live Panel Presentation: "Innovation is the Name of the Game: Novel Modalities for Oncology", September 28, 9:50am – 10:30am ET